Hormone Insight Titelbild

Hormone Insight

Hormone Insight

Von: FWA
Jetzt kostenlos hören, ohne Abo

Nur 0,99 € pro Monat für die ersten 3 Monate

Danach 9.95 € pro Monat. Bedingungen gelten.

Über diesen Titel

Discuss Diabetes and Endocrinology studies in a simplified manner. Expand your knowledge in Diabetes and Endocrinology.

Copyright 2024 FWA Wissenschaft
Folgen
  • Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)

    Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis)
    Jun 14 2025

    In this episode of Hormone Insight, we examine a 2024 post hoc analysis published in Diabetes Care.

    Mehr anzeigen Weniger anzeigen
    1 Min.
  • Exploring Semaglutide: Therapy for Obesity and Heart Failure

    Exploring Semaglutide: Therapy for Obesity and Heart Failure
    Jan 4 2025

    Exploring Semaglutide: Dual Action Therapy for Obesity and Heart Failure

    In this episode of Hormone Insights, we delve into a 2024 study from the New England Journal of Medicine that examines the effects of semaglutide in obese patients with heart failure, preserved ejection fraction, and type 2 diabetes.


    For full paper, click here


    Visit HormoneInsight
    Mehr anzeigen Weniger anzeigen
    1 Min.
  • Semaglutide vs Canagliflozin for Type 2 Diabetes

    Semaglutide vs Canagliflozin for Type 2 Diabetes
    Dec 19 2024

    In this episode of Hormone Insight, we delve into a major study published in The Lancet Diabetes and Endocrinology that compared the effects of semaglutide and canagliflozin as add-ons to metformin in diabetes treatment.


    For more: Semaglutide vs Canagliflozin for Type 2 Diabetes


    To read the original paper
    Mehr anzeigen Weniger anzeigen
    1 Min.
Noch keine Rezensionen vorhanden